Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomised, Placebo-controlled Clinical Trial of Simvastatin in Patients With Secondary Progressive Multiple Sclerosis.

NCT00647348 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT00647348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00647348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomised, Placebo-controlled Clinical Trial of Simvastatin in Patients With Secondary Progressive Multiple Sclerosis.
Lead sponsor
Imperial College London
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
November 30, 2011
Enrollment
140 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

secondary progressive multiple sclerosis